Similarly, variants in the 11223.3 chromosomal region involving APOA1, APOA4, APOA5, and APOC loci were reported to be strongly influencing the lipid levels and dyslipidemia in studies from northern (Braun et al., 2012) and southern India (Pranavchand and Reddy, 2017). This evidence concerns the gene APOA1 and metabolic syndrome.